{"DataElement":{"publicId":"3629943","version":"1","preferredName":"Access Route TCGA Route of Administration Type","preferredDefinition":"Text to represent an access route for the administration of agents or substances.","longName":"2012668v3.0:3629938v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2012668","version":"3","preferredName":"Access Route","preferredDefinition":"An established means of access (for administration of agents, taking vital signs, etc.).","longName":"ACCESS_RTE","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2635254","version":"1","preferredName":"Access","preferredDefinition":"The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","longName":"C25396","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Access","conceptCode":"C25396","definition":"The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6F5266-4618-4643-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2452898","version":"1","preferredName":"Route","preferredDefinition":"A method of achieving something. (from Cambridge Advanced Learner's Dictionary - online)","longName":"C25169","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route","conceptCode":"C25169","definition":"A way of getting from one place to another; an established line of travel or access; the way a chemical or pollutant enters an organism after contact, particularly, the way of drug administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6BC1-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"ONEDATA","dateModified":"2006-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A56E8150-8ED5-1CC3-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"REEVESD","dateModified":"2016-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3629938","version":"1","preferredName":"TCGA Route of Administration Type","preferredDefinition":"A comprehensive and coordinated effort to accelerate understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. This project is a joint effort of the National Cancer Institute and the National Human Genome Research Institute. (http://cancergenome.nih.gov/abouttcga)_Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration._Type; a subdivision of a particular kind of thing.","longName":"3629938v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Vaginal","valueDescription":"Vaginal Route of Administration","ValueMeaning":{"publicId":"2659979","version":"1","preferredName":"Vaginal Route of Administration","longName":"2659979","preferredDefinition":"Administration of a drug into the vagina. The medication usually has the form of a solution, tablet, cream, gel, or suppository. The drug is slowly absorbed through the vaginal wall with predominantly local, but some systemic effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Route of Administration","conceptCode":"C38313","definition":"Administration of a drug into the vagina. The medication usually has the form of a solution, tablet, cream, gel, or suppository. The drug is slowly absorbed through the vaginal wall with predominantly local, but some systemic effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BEA2A0-DA45-6CE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-25","modifiedBy":"DWARZEL","dateModified":"2016-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-8354-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Transdermal","valueDescription":"Transdermal Route of Administration","ValueMeaning":{"publicId":"2581012","version":"1","preferredName":"Transdermal Route of Administration","longName":"2581012","preferredDefinition":"Administration of a substance through the dermal layer of the skin into the systemic circulation by diffusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transdermal Route of Administration","conceptCode":"C38305","definition":"Administration of a substance through the dermal layer of the skin into the systemic circulation by diffusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0981-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-8369-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Topical","valueDescription":"Topical Route of Administration","ValueMeaning":{"publicId":"2577941","version":"1","preferredName":"Topical Route of Administration","longName":"2577941","preferredDefinition":"The application of a drug to a certain area of the skin or mucous membrane (including the intra-organ application), or other tissue locally, so that the agent will take effect on the surface and/or on the underlying tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Topical Route of Administration","conceptCode":"C38304","definition":"The application of a drug to a certain area of the skin or mucous membrane (including the intra-organ application), or other tissue locally, so that the agent will take effect on the surface and/or on the underlying tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD82-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-837D-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Subcutaneous (SC)","valueDescription":"Subcutaneous Route of Administration","ValueMeaning":{"publicId":"2578038","version":"1","preferredName":"Subcutaneous Route of Administration","longName":"2578038","preferredDefinition":"Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subcutaneous Route of Administration","conceptCode":"C38299","definition":"Drug administration beneath the skin. It provides for relatively slow, sustained release of the drug. The rate of absorption into the blood is perfusion-limited, proportional to the amount of drug at the site and can be enhanced by chemical or physical stimulation of blood flow. Subcutaneous administration minimizes the risks associated with intravascular injection: for subcutaneous infusions, external and implantable pumps are used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-8391-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Other (please specify)","valueDescription":"Specify Other Route of Administration","ValueMeaning":{"publicId":"3629939","version":"1","preferredName":"Specify Other Route of Administration","longName":"3629939","preferredDefinition":"Be specific about something; define clearly.: Route of drug administration not specified on this list.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other Route of Administration","conceptCode":"C38290","definition":"Route of drug administration not specified on this list.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-839E-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-83B7-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Oral (PO)","valueDescription":"Oral Route of Administration","ValueMeaning":{"publicId":"2581009","version":"1","preferredName":"Oral Route of Administration","longName":"2581009","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-097E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-83CB-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Intravesical","valueDescription":"Intravesical Route of Administration","ValueMeaning":{"publicId":"2577982","version":"1","preferredName":"Intravesical Route of Administration","longName":"2577982","preferredDefinition":"Administration within the bladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravesical Route of Administration","conceptCode":"C38278","definition":"The administration of a drug within the urinary bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-83DF-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Intravenous (IV)","valueDescription":"Intravenous Route of Administration","ValueMeaning":{"publicId":"2578035","version":"1","preferredName":"Intravenous Route of Administration","longName":"2578035","preferredDefinition":"Administration within or into a vein or veins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Route of Administration","conceptCode":"C38276","definition":"Administration of a drug within or into a vein or veins. Introduction of the drug directly into venous circulation results in 100% bioavailability due to an absence of the absorption phase, provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-83F3-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Intratumoral","valueDescription":"Intratumoral Route of Administration","ValueMeaning":{"publicId":"2578029","version":"1","preferredName":"Intratumoral Route of Administration","longName":"2578029","preferredDefinition":"The administration of a drug within or introduced directly into a tumor. Method allows to achieve high concentration of the agent in the tumor and delay drug release in systemic circulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intratumoral Route of Administration","conceptCode":"C38269","definition":"The administration of a drug within or introduced directly into a tumor. Method allows to achieve high concentration of the agent in the tumor and delay drug release in systemic circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDDA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-8407-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Intrathecal","valueDescription":"Intrathecal Route of Administration","ValueMeaning":{"publicId":"3629940","version":"1","preferredName":"Intrathecal Route of Administration","longName":"3629940","preferredDefinition":"Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrathecal Route of Administration","conceptCode":"C38267","definition":"Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-8411-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-842A-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Intra-peritoneal (IP)","valueDescription":"Intraperitoneal Route of Administration","ValueMeaning":{"publicId":"2578020","version":"1","preferredName":"Intraperitoneal Route of Administration","longName":"2578020","preferredDefinition":"Administration within the peritoneal cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraperitoneal Route of Administration","conceptCode":"C38258","definition":"Administration of a drug via injection or infusion of a substance into the peritoneum, where it is absorbed by the lining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDD1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-843E-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Intramuscular (IM)","valueDescription":"Intramuscular Route of Administration","ValueMeaning":{"publicId":"2578009","version":"1","preferredName":"Intramuscular Route of Administration","longName":"2578009","preferredDefinition":"Administration within a muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramuscular Route of Administration","conceptCode":"C28161","definition":"Intramuscular injection is a route of drug administration via injection into muscle tissue. Aqueous or oleaginous solutions and emulsions or suspensions may be administered. Absorption rates, delay in availability of the drug to the systemic circulation, and duration of effect are perfusion-limited, depend on molecular size of the agent, volume, and osmolarity of the drug solution, fat content of the injection site, and patient physical activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-8452-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Intrahepatic","valueDescription":"Intrahepatic Route of Administration","ValueMeaning":{"publicId":"3629942","version":"1","preferredName":"Intrahepatic Route of Administration","longName":"3629942","preferredDefinition":"Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic Route of Administration","conceptCode":"C38248","definition":"Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-845F-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-8478-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"},{"value":"Inhalation","valueDescription":"Inhalation Route of Administration","ValueMeaning":{"publicId":"2577932","version":"1","preferredName":"Inhalation Route of Administration","longName":"2577932","preferredDefinition":"Administration of a substance in the form of a gas, aerosol, or fine powder via the respiratory tract, usually by oral or nasal inhalation, for local or systemic effect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inhalation Route of Administration","conceptCode":"C38216","definition":"Administration of a substance in the form of a gas, aerosol, or fine powder via the respiratory tract, usually by oral or nasal inhalation, for local or systemic effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD79-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF057A49-848C-F346-E040-BB89AD432CDD","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3629937","version":"1","preferredName":"The Cancer Genome Atlas Route of Administration Type","preferredDefinition":"A comprehensive and coordinated effort to accelerate understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. This project is a joint effort of the National Cancer Institute and the National Human Genome Research Institute. (http://cancergenome.nih.gov/abouttcga):The course by which a substance was administered in order to reach the site of action in the body.:Something distinguishable as an identifiable class based on common qualities.","longName":"C98269:C38114:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Cancer Genome Atlas","conceptCode":"C98269","definition":"A comprehensive and coordinated effort to accelerate understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. This project is a joint effort of the National Cancer Institute and the National Human Genome Research Institute. (http://cancergenome.nih.gov/abouttcga)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-8322-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"ONEDATA","dateModified":"2012-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-8333-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"COOPERM","dateModified":"2012-12-03","changeDescription":"Created customized list for TCGA per request by A.Janning and released per approval from TCGA. mc 12/3/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Route","type":"Preferred Question Text","description":"Route","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF05D756-8A5E-FEC2-E040-BB89AD43086E","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Created for TCGA per request by A.Janning and released per TCGA approval. mc 12/3/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}